Psoriasis Treatment Center of New Jersey Reports Positive Results for Tapinarof in Psoriasis Trial

In this study, 52% of adult patients achieved the treat-to-target goal of 1% BSA or less within 3 months of incorporating tapinarof cream into their biologic regimen.

Related Keywords

New Jersey ,United States , ,National Psoriasis Foundation ,Psoriasis Treatment Center ,Schweiger Dermatology Group ,Dermatology Times ,Psoriasis Area ,Severity Index ,Tapinarof Cream For Psoriasis ,Tapinarof Clinical Trial ,